Item 9 Labs Corp (INLB)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Item 9 Labs Free Cash Flow (Quarterly): 0.0873M for June 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.0873M |
| March 31, 2023 | 0.3041M |
| December 31, 2022 | -1.342M |
| September 30, 2022 | -1.647M |
| June 30, 2022 | -2.073M |
| March 31, 2022 | -1.232M |
| December 31, 2021 | -2.760M |
| September 30, 2021 | 0.9116M |
| June 30, 2021 | -3.922M |
| March 31, 2021 | -2.790M |
| December 31, 2020 | -2.432M |
| September 30, 2020 | -0.068M |
| June 30, 2020 | -0.5799M |
| March 31, 2020 | -0.39M |
| December 31, 2019 | -0.5096M |
| September 30, 2019 | -2.489M |
| June 30, 2019 | -3.575M |
| March 31, 2019 | -1.958M |
| December 31, 2018 | -0.8296M |
| September 30, 2018 | -0.9002M |
| June 30, 2018 | -0.488M |
| March 31, 2018 | -0.0901M |
| December 31, 2017 | -0.04M |
| September 30, 2017 | 0.0734M |
| June 30, 2017 | -0.0123M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.0024M |
| December 31, 2016 | 0.0102M |
| September 30, 2016 | -0.0793M |
| June 30, 2016 | -0.0228M |
| March 31, 2016 | -0.1801M |
| December 31, 2015 | -0.0577M |
| September 30, 2015 | -0.1963M |
| June 30, 2015 | -0.1985M |
| March 31, 2015 | -0.1497M |
| December 31, 2014 | -0.2031M |
| September 30, 2014 | -0.1831M |
| June 30, 2014 | -0.2409M |
| March 31, 2014 | -0.1049M |
| December 31, 2013 | -0.2097M |
| September 30, 2013 | -0.03M |
| June 30, 2013 | -0.1832M |
| March 31, 2013 | -0.3035M |
| December 31, 2012 | 0.1276M |
| June 30, 2012 | -0.2158M |
| March 31, 2012 | -0.1233M |
| December 31, 2011 | -0.0331M |
| September 30, 2011 | 0.5227M |
| June 30, 2011 | -0.4498M |
| March 31, 2011 | -0.0802M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.922M
Minimum
Jun 2021
0.9116M
Maximum
Sep 2021
-1.442M
Average
-1.342M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Cantabio Pharmaceuticals Inc | -- |
| Q BioMed Inc | -0.1382M |
| NVN Liquidation Inc | -- |
| Affymax Inc | -- |
| Scopus BioPharma Inc | -1.009M |